Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors.
Mokbel S, Baciarello G, Lavaud P, Omlin A, Calabrò F, Cathomas R, Aeppli S, Parent P, Giannatempo P, Koster KL, Appel N, Gonnet P, Angius G, Tsantoulis P, Arkenau HT, Cattrini C, Messina C, Zeghondy J, Morelli C, Loriot Y, Formica V, Patrikidou A.
Mokbel S, et al. Among authors: koster kl.
Cancers (Basel). 2024 Apr 11;16(8):1465. doi: 10.3390/cancers16081465.
Cancers (Basel). 2024.
PMID: 38672547
Free PMC article.